Director/PDMR Shareholding
Summary by AI BETAClose X
SMITH & NEPHEW PLC
12 August 2026
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).
On 12 August 2026, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020 and Smith & Nephew Restricted Share Plan 2024.
VESTING OF 2023 PERFORMANCE SHARE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020 SHARE AWARD AGREEMENT
The awards vested on 12 August 2026 and a number of Shares were sold to cover the tax liability arising on the vesting. The number of Shares acquired includes the dividend equivalent Shares which participants receive on vested Shares. The table below sets out the number of shares under award which vested. The remaining shares under award have lapsed.
The following relates to individuals included in the below notification:
|
Reason for the notification |
|
|
Initial notification /Amendment |
Initial notification |
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
Name |
Smith & Nephew plc |
|
LEI |
213800ZTMDN8S67S1H61 |
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
Description of the financial instrument, type of instrument |
Smith & Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code |
ISIN: GB0009223206 |
|
Nature of the transaction |
Vesting of awards under the Smith & Nephew GSP 2020 Share Award Agreement followed by the sale of shares to cover the relevant tax liabilities. |
|
Date of Transaction |
12 August 2026 |
|
Place of Transaction |
London Stock Exchange (XLON) |
|
Name (Position) |
Status |
Price (£) |
Volume |
Aggregated information |
|
Rohit Kashyap (President, Advanced Wound Management and Global Commercial Operations) |
PDMR |
11.096264 |
23,202 (of which 9,163 were sold and 14,039 retained) |
N/A Single Transaction |
All figures in these columns are stated to 6 decimal places where applicable.
Philip Horner
Group Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 21 hours ago Savannah Energy
- 22 hours ago Buccaneer Energy PLC
- 23 hours ago Savannah Energy
- 23 hours ago Carclo
- 23 hours ago Schroder Japan Growth Fund